{"id":"W2492191474","doi":"10.1212/wnl.86.16_supplement.s49.003","title":"Efficacy of Ocrelizumab in Patients with Relapsing Multiple Sclerosis: Pooled Analysis of Two Identical Phase III, Double-Blind, Double-Dummy, Interferon Beta-1a-Controlled Studies (S49.003)","year":2016,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Montreal Neurological Institute and Hospital","funders":"","keywords":"Ocrelizumab; Multiple sclerosis; Medicine; Interferon beta-1a; Interferon beta; Double blind; Internal medicine; Oncology; Immunology; Pathology; Alternative medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03061279,0.003141784,0.01342763,0.001817591,0.0004136608,0.002581146,0.001064476,0.002479599,0.00148105],"category_scores_gemma":[0.02361382,0.001460601,0.02283002,0.001883207,0.001095921,0.001285538,0.00139486,0.001401992,0.0002469396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008789318,"about_ca_system_score_gemma":0.001303689,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001055142,"about_ca_topic_score_gemma":0.00178871,"domain_scores_codex":[0.9786456,0.01368929,0.003543831,0.002254808,0.001346771,0.0005197723],"domain_scores_gemma":[0.9849532,0.006296955,0.005244235,0.001676373,0.001280881,0.0005483929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4751049,0.0004679483,0.009106168,0.01231482,0.4842758,0.00009519829,0.00009317278,0.0009152245,0.003290831,0.00006552824,0.00040034,0.01387014],"study_design_scores_gemma":[0.2611398,0.03623355,0.04721165,0.0009216313,0.6483872,0.0002054894,0.0001037565,0.001238346,0.002255692,0.0002949801,0.001878612,0.0001291983],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6983194,0.2770179,0.008452121,0.0005190807,0.001121315,0.006643082,0.005675549,0.0004517302,0.001799884],"genre_scores_gemma":[0.9785246,0.01247117,0.003147437,0.0005373828,0.0003241029,0.002332244,0.002192324,0.00006096285,0.000409799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03061279,"threshold_uncertainty_score":0.1618979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09230576521324992,"score_gpt":0.3679096640933235,"score_spread":0.2756038988800736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}